Answers are grounded in this paper and cite their sources.
The C. pneumoniae workshop group on Detection, Culture, Serology, and Antimicrobial Susceptibility Testing made a strong and unanimous recommendation for the standardization of C. pneumoniae diagnostic tests. With many laboratories entering this field and introducing their own versions of diagnostic methods, it is becoming impossible to compare results between laboratories because there is no understanding of the sensitivity and specificity of the different diagnostic tests. Thus, the committee recommends that emphasis be placed on collaborative multicenter trials to evaluate and attempt to standardize existing diagnostic procedures. We encourage the Centers for Disease Control and Prevention or the World Health Organization to recommend common methodologies for multicenter trials and to identify “reference standards” and “reference reagents” (materials that could be used in all laboratories) whose use would ensure comparability of laboratory findings. In this same vein, the committee encouraged the development of commercial tests. These would allow for better comparability of results if the commercial tests were readily available and were used in different laboratories doing similar studies.
No takes yet. Share an insight, caveat, or question.
Tompkins et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: